Annual Operating Expenses
$194.21 M
+$3.77 M+1.98%
31 December 2023
Summary:
Poseida Therapeutics annual total operating expenses is currently $194.21 million, with the most recent change of +$3.77 million (+1.98%) on 31 December 2023. During the last 3 years, it has risen by +$67.66 million (+53.46%). PSTX annual operating expenses is now at all-time high.PSTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$52.01 M
-$5.72 M-9.91%
30 September 2024
Summary:
Poseida Therapeutics quarterly total operating expenses is currently $52.01 million, with the most recent change of -$5.72 million (-9.91%) on 30 September 2024. Over the past year, it has increased by +$6.43 million (+14.11%). PSTX quarterly operating expenses is now -10.94% below its all-time high of $58.40 million, reached on 31 March 2022.PSTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.0% | +14.1% |
| 3 y3 years | +53.5% | +25.0% |
| 5 y5 years | +378.9% | +163.9% |
PSTX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +53.5% | -10.9% | +25.0% |
| 5 y | 5 years | at high | +378.9% | -10.9% | +163.9% |
| alltime | all time | at high | +690.2% | -10.9% | +246.4% |
Poseida Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $52.01 M(-9.9%) |
| June 2024 | - | $57.73 M(+9.5%) |
| Mar 2024 | - | $52.72 M(+3.6%) |
| Dec 2023 | $194.21 M(+2.0%) | $50.90 M(+11.7%) |
| Sept 2023 | - | $45.57 M(-4.8%) |
| June 2023 | - | $47.87 M(-4.0%) |
| Mar 2023 | - | $49.86 M(+15.2%) |
| Dec 2022 | $190.44 M(+10.3%) | $43.27 M(-2.8%) |
| Sept 2022 | - | $44.53 M(+0.6%) |
| June 2022 | - | $44.24 M(-24.2%) |
| Mar 2022 | - | $58.40 M(+19.9%) |
| Dec 2021 | $172.65 M | $48.72 M(+17.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $41.59 M(-7.3%) |
| June 2021 | - | $44.88 M(+19.8%) |
| Mar 2021 | - | $37.46 M(+6.0%) |
| Dec 2020 | $126.55 M(+60.5%) | $35.36 M(+5.6%) |
| Sept 2020 | - | $33.47 M(+13.7%) |
| June 2020 | - | $29.45 M(+4.2%) |
| Mar 2020 | - | $28.27 M(+21.8%) |
| Dec 2019 | $78.85 M(+94.4%) | $23.21 M(+17.8%) |
| Sept 2019 | - | $19.70 M(-5.8%) |
| June 2019 | - | $20.92 M(+39.4%) |
| Mar 2019 | - | $15.01 M |
| Dec 2018 | $40.56 M(+65.0%) | - |
| Dec 2017 | $24.58 M | - |
FAQ
- What is Poseida Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Poseida Therapeutics?
- What is Poseida Therapeutics annual operating expenses year-on-year change?
- What is Poseida Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly operating expenses year-on-year change?
What is Poseida Therapeutics annual total operating expenses?
The current annual operating expenses of PSTX is $194.21 M
What is the all time high annual operating expenses for Poseida Therapeutics?
Poseida Therapeutics all-time high annual total operating expenses is $194.21 M
What is Poseida Therapeutics annual operating expenses year-on-year change?
Over the past year, PSTX annual total operating expenses has changed by +$3.77 M (+1.98%)
What is Poseida Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of PSTX is $52.01 M
What is the all time high quarterly operating expenses for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly total operating expenses is $58.40 M
What is Poseida Therapeutics quarterly operating expenses year-on-year change?
Over the past year, PSTX quarterly total operating expenses has changed by +$6.43 M (+14.11%)